Business Description
Sienna Biopharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US82622H1086
Description
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development, and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics. The objective is to develop multi-asset pipeline of topical therapies that enhance the health, appearance, and quality of life of dermatology patients. The product portfolio includes SNA-120, SNA-125, and SNA-001.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SNNAQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sienna Biopharmaceuticals Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2 | ||
| Beta | 164.2732 | ||
| 3-Year Sharpe Ratio | -59.39 | ||
| 3-Year Sortino Ratio | -3.46 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.0001 - 0.0001 | ||
| Shares Outstanding (Mil) | 30.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sienna Biopharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sienna Biopharmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-23 | In 146 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 45 days | ||
| First quarter earnings results for 2026 | 2026-07-08 | In 8 days | ||
| Annual report for 2025 | 2026-07-01 | In 1 day | ||
| General meeting for 2025 | 2026-07-01 | In 1 day |
Show
Entries
Sienna Biopharmaceuticals Inc Frequently Asked Questions
What is Sienna Biopharmaceuticals Inc(SNNAQ)'s stock price today?
The current price of SNNAQ is $0.00. The 52 week high of SNNAQ is $0.00 and 52 week low is $0.00.
When is next earnings date of Sienna Biopharmaceuticals Inc(SNNAQ)?
The next earnings date of Sienna Biopharmaceuticals Inc(SNNAQ) is 2026-07-08 Est..
Does Sienna Biopharmaceuticals Inc(SNNAQ) pay dividends? If so, how much?
Sienna Biopharmaceuticals Inc(SNNAQ) does not pay dividend.
Guru Commentaries on OTCPK:SNNAQ
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Sienna Biopharmaceuticals Inc
No articles.